Reported Mar 11, 2020 · Terminated
Lidocaine HCL (PF) Injection, LIDOCAINE HCL 4% (PF) 40 MG/ML INJECTABLE, For ocular injection, Preservative free,…
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · 1990 Westwood Blvd Ste 135 · Los Angeles, CA · 90025-4650
Is this the product you have?
- Lidocaine HCL (PF) Injection, LIDOCAINE HCL 4% (PF) 40 MG/ML INJECTABLE, For ocular injection, Preservative free, discard unused portion, protect from light, 5 mL Single-use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-1011-5
- Lot codes and dates
Lot #: 07012019+52569Exp 3/15/2020
- Amount recalled
- N/A
This recall covers 63 products
The agency filed one notice per product. You are reading one of them; the other 62 are below.
50 more are in the archive.
Where it was sold
- Nationwide
- PR
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Fusion IV Pharmaceuticals, Inc. dba Axia… recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.